Cargando…

Lipoprotein Subclasses Associated With High‐Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial

BACKGROUND: More than half of major adverse cardiovascular events (MACE) occur in the absence of obstructive coronary artery disease and are often attributed to the rupture of high‐risk coronary atherosclerotic plaque (HRP). Blood‐based biomarkers that associate with imaging‐defined HRP and predict...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGarrah, Robert W., Ferencik, Maros, Giamberardino, Stephanie N., Hoffmann, Udo, Foldyna, Borek, Karady, Julia, Ginsburg, Geoffrey S., Kraus, William E., Douglas, Pamela S., Shah, Svati H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973611/ https://www.ncbi.nlm.nih.gov/pubmed/36565187 http://dx.doi.org/10.1161/JAHA.122.026662

Ejemplares similares

Branched‐Chain Amino Acids in Computed Tomography–Defined Adipose Depots and Coronary Artery Disease: A PROMISE Trial Biomarker Substudy
por: Zhao, Elizabeth, et al.
Publicado: (2023)

Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
por: Newman, Jonathan D., et al.
Publicado: (2022)

Risk factors for cardiovascular disease among individuals with hepatic steatosis
por: Karády, Julia, et al.
Publicado: (2022)

Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain
por: Karády, Júlia, et al.
Publicado: (2020)

Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes
por: Lerman, Joseph B., et al.
Publicado: (2022)

Relationship between subclasses low-density lipoprotein and carotid plaque
por: Pan, Zhanhai, et al.
Publicado: (2022)

Guideline-Based Statin Eligibility, Coronary Artery Stenosis and Cardiovascular Events in Patients with Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
por: Pursnani, Amit, et al.
Publicado: (2020)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy
por: Truby, Lauren K., et al.
Publicado: (2021)

Cystatin C as a Promising Biomarker of Atherosclerotic Plaque
por: Sawada, Shojiro
Publicado: (2021)

If You’re Ready, I Am Ready (But the Wait Is Harming Us Both) Individual Risks in Institutional Conversions
por: Sharp, Mindy McGarrah
Publicado: (2020)

Radiomics versus Visual and Histogram-based Assessment to Identify Atheromatous Lesions at Coronary CT Angiography: An ex Vivo Study
por: Kolossváry, Márton, et al.
Publicado: (2019)

Pedagogies of Possibilities: Liberating Moral Imagination by Practicing Pastoral Aesthetics
por: Sharp, Melinda A. McGarrah
Publicado: (2021)

Novel plasma biomarkers improve discrimination of metabolic health independent of weight
por: Ellison, Stephen, et al.
Publicado: (2020)

Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street
por: White, Phillip J., et al.
Publicado: (2021)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
por: Chalmers, Alexander D., et al.
Publicado: (2017)

The prevention and regression of atherosclerotic plaques: emerging treatments
por: Kalanuria, Atul Ashok, et al.
Publicado: (2012)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Radiomic Features Are Superior to Conventional Quantitative Computed Tomographic Metrics to Identify Coronary Plaques With Napkin-Ring Sign
por: Kolossváry, Márton, et al.
Publicado: (2017)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Classification of human coronary atherosclerotic plaques with T1, T2 and Ultrashort TE MRI
por: Karolyi, Mihaly, et al.
Publicado: (2012)

Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health
por: Streese, Lukas, et al.
Publicado: (2022)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease
por: Niccoli, Giampaolo, et al.
Publicado: (2016)

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
por: Zhou, Boda, et al.
Publicado: (2017)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques
por: Li, Yuxin, et al.
Publicado: (2016)

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A(2) and carboxyl ester lipase lipases in atherosclerotic plaque formation
por: Burchardt, Paweł, et al.
Publicado: (2013)

The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
por: Tian, Li, et al.
Publicado: (2011)

The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
por: Tian, Li, et al.
Publicado: (2010)

Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?
por: Bays, Harold, et al.
Publicado: (2010)

The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome
por: Tian, Li, et al.
Publicado: (2014)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

The Elusive Origin of Atherosclerotic Plaque Calcification
por: Canet-Soulas, Emmanuelle, et al.
Publicado: (2021)

Clinical Molecular Imaging for Atherosclerotic Plaque
por: Kondakov, Anton, et al.
Publicado: (2021)

Cellular crosstalk in atherosclerotic plaque microenvironment
por: Mahdinia, Elmira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_50p8u92ouuobjmu1i9g18rgi11